Jiwoong Chun
Investment leader @ KTB Network
Jiwoong Chun is a Series B investor at KTB Network focused on Health Care and Therapeutics. Jiwoong Chun is the Board Member of Illimis Therapeutics. Jiwoong Chun attended Seoul National University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Jiwoong Chun invests in
Stages Jiwoong Chun invests in
Countries Jiwoong Chun invests in
Investment Focus
Industry
- Health Care 2 (100%)
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Biopharma 1 (50%)
- Pharmaceutical 1 (50%)
Country
- Taiwan 1 (50%)
- South Korea 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Illimis Therapeutics
|
Illimis Therapeutics is a platform-based biotech company that develops a chimeric fusion protein platform for neurodegenerative diseases. The company's proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform is designed to harness the therapeutic potential of TAM (Tyro3, Axl, Mer) receptor biology, a critical pathway involved inregulating inflammation and immune responses. | $41.9M / Series B / Jul 14, 2025 | |
APRINOIA Therapeutics
|
APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing outcomes of neurodegenerative diseases through first-in-class and best-in-class diagnostic tools and novel therapies. The company aims to bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau,alpha-synuclein and other proteins that play a critical role in the pathogenesis of many neurodegenerative diseases, such as Alzheimer's and Parkinson's Diseases. The company currently has operations in Hong Kong, Suzhou, Shanghai, Tokyo, and Boston. | $11.1M / Series B / Jan 16, 2018 |
Co-Investors
About KTB Network
Korea Technology Development Company, a government-funded investment vehicle specializing in technology-related investment opportunities, KTB Financial Group(“KTB”) has since grown into a comprehensive financial group offering a wide range of financial services, including securities, asset management, venture capital, and private equity.KTB alsohas expanded our global network by actively entering overseas markets includes the United States, China, and Thailand.
KTB Network Contacts
| Name | Phone | Socials | |
|---|---|---|---|
HoChan Lee
Managing Director
|
|||
Ji Eun Lee
Team Manager
|
|||
|
Jinho Shin
CEO
|
|||
|
Jiwoong Chun
Investment leader
|
|||
|
Kevin Kuk-Hyun Kyung
Team Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jiwoong Chun invest in?
Jiwoong Chun invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jiwoong Chun last invest?
The most recent investment recorded for Jiwoong Chun closed in Jul 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
